Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Department of Dermatology, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Exp Dermatol. 2014 Feb;23(2):125-9. doi: 10.1111/exd.12322.
Skin pigmentation is a complex process including melanogenesis within melanocytes and melanin transfer to the keratinocytes. To develop a comprehensive screening method for novel pigmentation regulators, we used immortalized melanocytes and keratinocytes in co-culture to screen large numbers of compounds. High-throughput screening plates were subjected to digital automated microscopy to quantify the pigmentation via brightfield microscopy. Compounds with pigment suppression were secondarily tested for their effects on expression of microphthalmia transcription factor (MITF) and several pigment regulatory genes, and further validated in terms of non-toxicity to keratinocytes/melanocytes and dose-dependent activity. The results demonstrate a high-throughput, high-content screening approach, which is applicable to the analysis of large chemical libraries using a co-culture system. We identified candidate pigmentation inhibitors from 4000 screened compounds including zoxazolamine, 3-methoxycatechol and alpha-mangostin, which were also shown to modulate expression of MITF and several key pigmentation factors and are worthy of further evaluation for potential translation to clinical use.
皮肤色素沉着是一个复杂的过程,包括黑素细胞中的黑素生成和黑色素向角质形成细胞的转移。为了开发一种全面的新型色素沉着调节剂筛选方法,我们使用永生化的黑素细胞和角质形成细胞共培养来筛选大量化合物。高通量筛选板通过明场显微镜进行数字化自动显微镜检查,以量化色素沉着。具有色素抑制作用的化合物将进一步测试其对小眼畸形转录因子(MITF)和几个色素调节基因表达的影响,并根据对角质形成细胞/黑素细胞的毒性和剂量依赖性活性进行进一步验证。结果表明,该方法是一种高通量、高内涵筛选方法,适用于使用共培养系统分析大型化学文库。我们从 4000 种筛选化合物中鉴定出候选的色素沉着抑制剂,包括唑拉胺、3-甲氧基儿茶酚和α-倒捻子素,它们还被证明可以调节 MITF 和几个关键色素调节因子的表达,值得进一步评估,以潜在地转化为临床应用。